
KORU MEDICAL SYSTEMS INC
KRMDNASDAQTrading Snapshot
- Day Range
- $3.43 โ $3.51
- 52-Week Range
- $3.21 โ $6.61
- Volume
- $3.09B
- Avg Volume
- $3.05B
- Shares Outstanding
- 45.9M
- Next Earnings
- Oct 3, 2026
Fundamentals Snapshot
- Annual Revenue
- $41M
- Last Q Revenue
- $12M
- P/E Ratio
- โ
- P/S Ratio
- 3.5x
- EPS (TTM)
- $-0.04
- Dividend Yield
- โ
Why Investors Own KRMD
- โHigh-growth profile โ revenue up +36.3% YoY with expanding US Equity exposure.
- โHealthy economics โ 37% gross margin and 21% free-cash-flow margin.
- โNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About KORU MEDICAL SYSTEMS INC
KORU Medical Systems, Inc. is dedicated to the development, manufacturing, and commercialization of mobile medical devices, primarily serving the ambulatory infusion market across both the United States and international territories. The company's primary offerings revolve around mechanical infusion solutions, notably their FREEDOM infusion systems. These comprehensive systems encompass components such as the FREEDOM60 and FreedomEdge syringe drivers, alongside specialized HIgH-Flo subcutaneous safety needle sets and precision flow rate tubing. Beyond their product range, KORU Medical also supplies educational content and training materials to healthcare professionals, patients, and patient advocates. The distribution of their products is managed through a combination of direct sales efforts, partnerships with medical device distributors, and online channels. Established in 1980, the firm's corporate headquarters are situated in Chester, New York.
Otter Score Breakdown
โAnalyst Ratings
โLatest News & Updates

KORU Medical Systems Inc (KRMD) (Q2 2026) Earnings Call Highlights: Record Revenue and First ...
Company achieves 18% revenue growth and raises gross margin guidance despite international headwinds and FESGO withdrawal.

KORU Medical Systems Q2 Earnings Call Highlights
KORU Medical Systems (NASDAQ:KRMD) reported second-quarter revenue of $12 million, up 18% from a year earlier, as domestic patient starts, market-share gains and international demand supported growth. The company also said it achieved positive net income for the first time since 2019 and raised its

KORU Medical Systems, Inc. Q2 2026 Earnings Call Summary
Moby summary of KORU Medical Systems, Inc.'s Q2 2026 earnings call
Koru Medical Systems (NASDAQ:KRMD) Slips on Full-Year Revenue Guidance Cut and U.S. Oncology Strategic Pivot
Koru Medical (KRMD) Q2: revenue in line, EPS surprise positive, but full-year revenue guidance below consensus and U.S. oncology pivot weigh on shares.

KORU Medical Systems, Inc. (KRMD) Q2 2026 Earnings Call Transcript
KORU Medical Systems, Inc. (KRMD) Q2 2026 Earnings Call August 5, 2026 4:30 PM EDTCompany ParticipantsAdam Kalbermatten - President & CEOTom Adams -...

KORU Medical Systems, Inc. 2026 Q2 - Results - Earnings Call Presentation
2026-08-05. The following slide deck was published by KORU Medical Systems, Inc.